NCT05937594View on ClinicalTrials.gov

MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

December 10, 2025

Study Completion Date

April 10, 2026

Conditions
Neonatal Opioid Withdrawal SyndromeNeonatal Abstinence Syndrome
Interventions
GENETIC

Buccal swab saliva for further genetic testing

Genetic testing. Whole saliva RNA will be isolated for downstream microRNA quantification.

Trial Locations (1)

17033

RECRUITING

Penn State Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Milton S. Hershey Medical Center

OTHER